Elena Stavrakas is a director in the Healthcare life sciences practice. Since joining Navigant in 2008, Elena has specialized in biopharmaceutical strategic commercial advisory with particular focus in rare diseases, commercial launch excellence, as well as M&A and business development strategy. She has more than 10 years of experience in life sciences, beginning her career in healthcare investment banking and transitioning into consulting.
While in investment banking, Elena worked closely with management teams of private and public clinical stage pharmaceutical and biotech firms on strategic planning and financial transactions. Additionally, Elena conducted analyses for venture and private equity fundraising, public offerings, fairness opinions, M&A, and other financial advisory assignments.
Elena has recently focused on a variety of client advisory offerings becoming a long-term partner within several key accounts. Her most recent areas of specialty include delivery of complex disease area strategies, onsite brand planning and execution support, prioritization of acquisition opportunities, clinical trial improvement technology, and forecast model design and implementation. From a therapeutic area perspective, Elena’s expertise is focused on central nervous syndrome disorders, psychiatry, nephrology, and oncology.